Crossmark

Post-marketing safety surveillance of tarlatamab: a real-world pharmacovigilance study based on the FAERS database

Published Online: 2026-01-29

Authors

Jin, Xiaoni

Zhao, Weixing https://orcid.org/0009-0001-1291-4788
Li, Yuan

Peng, Huiyuan
License Information

Text and Data Mining valid from 2026-01-29

Version of Record valid from 2026-01-29
More Information

Article History

Received: 24 August 2025

Accepted: 18 January 2026

First Online: 29 January 2026

Declarations

:

: Because this study was an observational study using a global open database (FAERS) with anonymized information, not involving treatment intervention or collection of human samples, informed consent was exempted.

: Not applicable.

: The authors declare no competing interests.

Document is current